Related references
Note: Only part of the references are listed.Genetic Lesions of Type I Interferon Signalling in Human Antiviral Immunity
Christopher J. A. Duncan et al.
TRENDS IN GENETICS (2021)
Opposing activities of IFITM proteins in SARS-CoV-2 infection
Guoli Shi et al.
EMBO JOURNAL (2021)
Electrolyte imbalance in COVID-19 patients admitted to the Emergency Department: a case-control study
Hugo De Carvalho et al.
INTERNAL AND EMERGENCY MEDICINE (2021)
IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2
Romain Levy et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2021)
Genetic mechanisms of critical illness in COVID-19
Erola Pairo-Castineira et al.
NATURE (2021)
Global absence and targeting of protective immune states in severe COVID-19
Alexis J. Combes et al.
NATURE (2021)
Strong Correlation between the Case Fatality Rate of COVID-19 and the rs6598045 Single Nucleotide Polymorphism (SNP) of the Interferon-Induced Transmembrane Protein 3 (IFITM3) Gene at the Population-Level
Yong-Chan Kim et al.
GENES (2021)
Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019
Yonghong Zhang et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Presence of Genetic Variants Among Young Men With Severe COVID-19
Caspar I. van der Made et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19
Camila Rosat Consiglio et al.
CELL (2020)
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Carolyn Rydyznski Moderbacher et al.
CELL (2020)
Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)
Conor N. Gruber et al.
CELL (2020)
Sex differences in immune responses that underlie COVID-19 disease outcomes
Takehiro Takahashi et al.
NATURE (2020)
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
Idoia Busnadiego et al.
MBIO (2020)
Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease
Lindsey E. Fox et al.
FRONTIERS IN IMMUNOLOGY (2020)
Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces
Megan L. Stanifer et al.
FRONTIERS IN IMMUNOLOGY (2020)
Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19
Yu Zuo et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Explaining among-country variation in COVID-19 case fatality rate
Gabriele Sorci et al.
SCIENTIFIC REPORTS (2020)
Shared and Distinct Functions of Type I and Type III Interferons
Helen M. Lazear et al.
IMMUNITY (2019)
Severe influenza pneumonitis in children with inherited TLR3 deficiency
Hye Kyung Lim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency
Nicholas Hernandez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus
Scott A. Jenks et al.
IMMUNITY (2018)
Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection
Adrienne G. Randolph et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans
E. Kaitlynn Allen et al.
NATURE MEDICINE (2017)
Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs
Kevin Tartour et al.
PLOS PATHOGENS (2017)
AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies
Steffen Meyer et al.
CELL (2016)
Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview
Mathieu P. Rodero et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Viral infections in type 1 diabetes mellitus - why the β cells?
Anne Op de Beeck et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency
Jolan E. Walter et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency
Michael J. Ciancanelli et al.
SCIENCE (2015)
IFITM Proteins Incorporated into HIV-1 Virions Impair Viral Fusion and Spread
Alex A. Compton et al.
CELL HOST & MICROBE (2014)
Autoimmunity due to RAG deficiency and estimated disease incidence in RAG1/2 mutations
Karin Chen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Molecular Mimicry between Dengue Virus and Coagulation Factors Induces Antibodies To Inhibit Thrombin Activity and Enhance Fibrinolysis
Yung-Chun Chuang et al.
JOURNAL OF VIROLOGY (2014)
Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection
Zhongfang Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity
Kevin Tartour et al.
RETROVIROLOGY (2014)
IFITM3 Restricts Influenza A Virus Entry by Blocking the Formation of Fusion Pores following Virus-Endosome Hemifusion
Tanay M. Desai et al.
PLOS PATHOGENS (2014)
Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals
Yong-Hong Zhang et al.
NATURE COMMUNICATIONS (2013)
Constitutive Type I Interferon Modulates Homeostatic Balance through Tonic Signaling
Daniel J. Gough et al.
IMMUNITY (2012)
IFITM3 restricts the morbidity and mortality associated with influenza
Aaron R. Everitt et al.
NATURE (2012)
IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry
Eric M. Feeley et al.
PLOS PATHOGENS (2011)
Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus
I-Chueh Huang et al.
PLOS PATHOGENS (2011)
Serum-induced suppression of interferon (IFN) activity. Lack of evidence for the presence of specific autoantibodies to IFN-α in normal human sera
M. B. HANSEN et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Naturally occurring anti-interferon-α2a antibodies in patients with acute viral hepatitis
Y. IKEDA et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines
Kai Kisand et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus
Abraham L. Brass et al.
CELL (2009)
Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1
Anthony Meager et al.
PLOS MEDICINE (2006)
Share Paper
